Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
COSTS AND EXPENSES:        
Research and development $ 5,052 $ 3,264 $ 12,502 $ 12,501
General and administrative 2,839 2,277 7,592 6,171
Total costs and expenses 7,891 5,541 20,094 18,672
Operating Loss (7,891) (5,541) (20,094) (18,672)
Interest income, net 53 62 183 171
NET LOSS $ (7,838) $ (5,479) $ (19,911) $ (18,501)
Net loss per common share, basic and diluted (in dollars per share) $ (5.69) $ (54.99) $ (23.93) $ (195.51)
Weighted average common shares outstanding, basic and diluted (in shares) 1,377,857 99,640 832,050 94,628